The pharmacologic studies have demonstrated that 111In/68Ga-DOTA-(HE)3-ADAPT6 is specifically taken up by HER2+ tumors, with a high tumor-to-normal tissue ratio in mice xenograft tumor models. Here, ERBB2 is linked to neoplasm.